
==== Front
Radiol Case Rep
Radiol Case Rep
Radiology Case Reports
1930-0433
Elsevier

S1930-0433(24)00825-2
10.1016/j.radcr.2024.08.041
Case Report
Recurrent gastric intramural pseudocyst: A case report and comprehensive literature review of reported cases
Soltani Amirhossein MD ac
Salimi Mohsen MD mohsenwork98@gmail.com
mohsensalimi@sums.ac.ir
b⁎
Nemati Maryam MD b
Mirshamsi Ali MD b
a Department of Radiology, Shiraz University of Medical Sciences, Shiraz, Iran
b Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
c Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
⁎ Corresponding author. mohsenwork98@gmail.commohsensalimi@sums.ac.ir
03 9 2024
11 2024
03 9 2024
19 11 54295441
4 8 2024
7 8 2024
10 8 2024
© 2024 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
2024

https://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Intramural gastric pseudocysts are extremely rare and are often associated with pancreatitis and pancreatic pseudocysts; they can lead to complex clinical presentations requiring careful diagnosis and management. We present a case of a 57-year-old man with a history of pancreatitis and pancreatic pseudocysts who was diagnosed with intramural gastric pseudocysts. The patient was diagnosed with multiple gastric intramural pseudocysts at different locations during separate admissions and imaging studies. This indicates a recurrence of gastric intramural pseudocysts. In these cases, studies rarely discuss recurrence and its underlying causes. This highlights a significant gap in the existing literature.

To provide a broader understanding, we reviewed the literature by searching major databases (PubMed, Scopus, and Web of Science) and then extracted and analyzed data from 18 articles, reaching 24 similar cases. Of the 25 patients studied (including our case), 92% were male and 8% were female. Cases had a mean age of 47.68 ± 14.82 years. Additionally, 84% of the patients had a history of alcohol consumption, and 88% had a positive history of pancreatitis. Common symptoms were abdominal pain (especially in the epigastric region), vomiting, nausea, and weight loss. In conclusion, results showed that intramural gastric pseudocysts generally occur in middle-aged men with a history of chronic or heavy alcohol consumption and pancreatitis.

Keywords

Intramural gastric pseudocyst
Pancreatic pseudocyst
Pseudocyst
Chronic pancreatitis
Necrotizing pancreatitis
Abbreviations

EUS Endoscopic Ultrasound

CT Computed Tomography

MRCP Magnetic Resonance Cholangiopancreatography

CBD Common Bile Duct

MPD Main Pancreatic Duct

ERCP Endoscopic Retrograde Cholangiopancreatography

MRI Magnetic Resonance Imaging

CRP C-reactive Protein

ESR Erythrocyte Sedimentation Rate

WBC White Blood Cell (count)

ALP Alkaline Phosphatase

UTI Urinary Tract Infection

US Ultrasonography

CECT Contrast-Enhanced Computed Tomography

CEA Carcinoembryonic Antigen

AIP Autoimmune Pancreatitis

UGI Upper Gastrointestinal (series)

FNA Fine Needle Aspiration

GIST gastrointestinal stromal tumors
==== Body
pmcIntroduction

Gastrointestinal intramural pseudocysts are extremely rare. Potentially, they may develop in the esophagus, stomach, duodenum, and colon. Among these, gastric intramural pseudocysts are very uncommon and have only been documented in case studies in the current literature up until now [1,2].

The term “intramural gastric pseudocyst” was first used by H. M. Radke and J. W. Bell in 1966. They described it as an amylase-containing fluid collection within the layers of the gastric wall, occurring after chronic pancreatitis [3]. However, today we know that it can occur after both chronic and acute pancreatitis [4].

The pathophysiology of intramural gastric pseudocysts has not been thoroughly clarified. Possible explanations are the rupturing of a pancreatic pseudocyst into the gastric walls, the existence of a fistula connecting the pancreas and the gastrointestinal tract, and the inflammation of heterotopic pancreatic tissue located in the gastrointestinal tract wall [1,5].

In this case report, we will describe a patient with recurrent intramural gastric cysts following chronic pancreatitis. Studies have rarely discussed this condition in terms of recurrence, its underlying causes, and pathophysiology, which highlights a significant gap in the existing literature. Then we will look into the imaging characteristics of this condition and review the literature to gather reported cases. Finally, we will perform a comprehensive review of the literature and an overview of reported cases to go much deeper into the disease and to guide future research and clinical management of this condition by addressing the current gap in the literature.

Case presentation

A 57-year-old man with a medical history of diabetes mellitus, chronic pancreatitis, chronic smoking, and ischemic heart disease and no history of alcohol consumption, was diagnosed with intramural gastric pseudocyst. Over the past 4 years, the patient has multiple hospitalizations with similar symptoms.

During his first hospitalization 4 years ago (first hospitalization), the patient was diagnosed with acute necrotizing pancreatitis complicated by multiple pancreatic pseudocysts (Fig. 1). The pseudocysts caused a compression effect on the gastric outlet, leading to gastric outlet obstruction. Left portal vein thrombosis was also noted in a series of patient imaging studies. The patient underwent an exploratory laparotomy. A cholecystectomy was performed due to cholecystitis with stones, and after that, drainage of the pancreatic pseudocysts was done with partial resection of the body of the pancreas.Fig. 1 Abdominal CT scan–Axial view: The pancreas shows diffuse inhomogeneous parenchymal density and enhancement. Some areas of decreased enhancement are seen in the pancreatic tail, associated with peri-pancreatic fat stranding, suggestive of acute necrotizing pancreatitis. Evidence of pseudocyst formation is noted in the pancreas, measuring 38 × 43 mm (red arrow).

Fig 1

The patient returned to the hospital again after 2 years (second hospitalization), showing symptoms that were similar to the previous ones. He has been diagnosed with pancreatitis once again. An abdominal CT scan revealed the existence of 2 new cystic structures located in the greater curvature of the fundus and stomach body (Fig. 2). The patient was discharged after receiving conservative treatment.Fig. 2 (A-C) Abdomen and pelvic CT scan, Axial and Coronal views: (A) The head and tail of the pancreas show normal size with mild inhomogeneous parenchymal density. The body of the pancreas is not seen due to previous resection. No evidence of pancreatic pseudocyst is seen. (B) Evidence of 2 newly cystic structures measuring up to 20 × 19 mm is seen in the greater curvature of the stomach. According to the patient's medical history, this is suggestive of an intramural gastric pseudocyst (2 yellow arrows). (C) Multiple stones are seen in the common bile duct (CBD) (red arrow), associated with dilatation of the common bile duct (red arrow) and intrahepatic bile ducts (yellow arrows) as the cause of recurrent pancreatitis.

Fig 2 (

A year ago, a patient was admitted due to a urinary tract infection (UTI) (third hospitalization), in his abdominal CT scan, we observed several peripheral enhancing cystic structures in the upper part of the stomach, which were associated with significant adjacent mesenteric fat inflammation. The gastro-esophageal junction revealed the largest cystic structure, along with the presence of lymphadenopathy. These findings were consistent with intramural gastric pseudocysts. However, due to his being asymptomatic, no further workup was done for him.

In this last and present admission (fourth and present hospitalization), the patient presented with epigastric pain, nausea, and postprandial vomiting (nonbloody, nonbilious) since a day ago. He was hemodynamically stable with a normal temperature. On physical examination, he had mild tenderness in the epigastric region without any abdominal distention. The patient's blood tests showed a high total leukocyte count (WBC) of 13.8×10^3/µL (normal reference range: 4.8-10.8×10^3/µL), elevated C-reactive protein (CRP) of 66 mg/L (normal reference range: <6 mg/L), erythrocyte sedimentation rate (ESR) of 20 mm/h (normal reference range: <20 mm/h), elevated serum amylase level of 558 IU/L (normal reference range: 20-100 IU/L), elevated serum lipase of 608 IU/L (normal reference range: 5-60 IU/L), and elevated serum alkaline phosphatase (ALP) of 866 IU/L (normal reference range: 100-390 IU/L). The rest of the liver function tests were unremarkable.

The computed tomography (CT scan) revealed evidence of multiple cystic structures of varying sizes with peripheral enhancement seen in both the lesser and greater curvatures of the stomach, suggestive of gastric intramural pseudocysts. In comparison with previous studies, a new cystic structure was observed, indicating recurrent gastric intramural pseudocysts in the patient (Fig. 3). Due to dilation of the common bile duct and intrahepatic bile ducts, performing magnetic resonance cholangiopancreatography (MRCP) was suggested for further correlation.Fig. 3 (A and B) Abdomen and pelvic CT scan, coronal and axial Views: A newly relatively thick-walled cystic structure measuring 65 × 53 mm is seen in the epigastric region, arising from the lesser curvature of the stomach, suggestive of an intramural gastric pseudocyst (red arrow). This is in addition to the 2 previously noted cystic structures in the greater curvature.

Fig 3 (

Magnetic resonance cholangiopancreatography (MRCP) showed multiple stones in the hepatic ducts and common bile duct (CBD). We also observed irregular dilation of the main pancreatic duct (MPD) at the tail of the pancreas and atrophic changes in the head and tail of the pancreas. The body and fundus of the stomach displayed significant inflammation and wall thickening, and the lesser curvature revealed a 65 × 55 mm cystic structure posterior to the fundal part of the stomach (Fig. 4).Fig. 4 (A-C) Magnetic resonance cholangiopancreatography (MRCP), coronal and axial views: Evidence of a cystic structure with high T2 signal intensity arising from the lesser curvature of the stomach (red arrow). Additionally, there is evidence of multiple other cystic structures in the intramural aspect of the lesser curvature of the stomach (yellow arrow). Multiple stones are seen in the common bile duct, associated with dilation (white arrow) as a cause of recurrent pancreatitis.

Fig 4 (

Patient outcome

The patient underwent endoscopic retrograde cholangiopancreatography (ERCP) during his last admission. After becoming stable and symptom-free, he was discharged from the hospital. Since then, all subsequent follow-up appointments have been uneventful.

Literature review

We performed a systematic literature search using the PubMed, Embase, Scopus, and Web of Science (all databases) databases. A search was done using the different combinations of “gastric pseudocyst”, “gastric intramural pseudocyst”, “intramural pseudocyst”, “gastric”, “stomach” and “pseudocyst” keywords. There were no limitations on the publication date, language, or type of article set at this stage. After combining the search results, we identified a total of 597 articles. The articles were imported into EndNote version 20.0, where duplicates were manually reviewed and deleted, resulting in 233 articles remaining for title and abstract screening. Two medical doctors independently performed the title and abstract screening. The inclusion criteria were articles in English, human studies, and studies explicitly discussing gastric intramural pseudocyst formation. We excluded articles written in languages other than English, animal studies, unrelated articles, studies mentioning gastric pseudocyst detection along with etiology of ectopic or heterotopic pancreas, and partially related articles that didn't explicitly mention intramural gastric pseudocyst detection. Title and abstract screening identified 19 articles that met the inclusion criteria. Full-text screening was performed by the same reviewers, and all 19 studies were included.

These consisted mainly of case reports, but to ensure comprehensiveness given the rarity of the condition, we also included patients reported in letters, conference abstracts, and posters, as well as 2 articles published in sections named “Image of the Month”. To avoid case duplication, we excluded 1 article that shared the same authorship with another included study.

We identified a total of 24 patients with intramural gastric pseudocysts from the 18 included articles [[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16], [17], [18]]. Including our reported case, the total number of patients analyzed was 25 (Table 1). We then extracted and analyzed the data.Table 1 Characteristics of Gastric Pseudocysts cases reported in the literature including our case.

Table 1Study	Age	Gender	Alcohol consumption	Underlying cause	History of pancreatitis	Pancreatic pseudocyst	Signs and symptoms	Size	Amylase fluid content	Treatment	
Ahuja et.al [6]	36	Female	Yes	Alcohol	Acute	No	Nausea, Abdominal pain (Upper), Vomiting (Bilious), Weight loss.	4.4 cm	18170
U/L	Fluoroscopy-guided drainage	
Atiq et. al [7]	46	Male	Yes	Alcohol	Acute	Yes	Abdominal pain, Vomiting, Nausea	Not mentioned	Not mentioned	Aspiration through Surgery	
Chiu et. al [8]	32	Male	Yes	Alcohol	Chronic	Yes	Epigastric pain	2 cm	6320 U/L	Endoscopic aspiration	
Dong et. al [9]	45	Female	No	Not mentioned	Yes, but the type not mentioned	Yes	Abdominal pain	4.6 cm	Not mentioned	Conservative	
Hatamori et. al [10]	67	Male	No	type
1 autoimmune pancreatitis (AIP)	type
1 autoimmune pancreatitis (AIP)	No	Enlargement of the pancreas	7 cm	22743 U/L	EUS-guided cyst drainage	
Koop et. al [4]	41	Male	Yes	Alcohol	Acute	No	Abdominal pain (upper)	4 cm	39152 U/L	Surgery	
Kumar et. al [11]	30	Male	Yes	Alcohol	Acute	No	Epigastric pain	2.5 cm	132600 IU/L	Not mentioned	
Luigiano et. al [12]	66	Male	Yes	Alcohol	Chronic	No	Epigastric pain, Heartburn, Vomiting	3 cm	108570 U/L	Fine needle aspiration (FNA)	
Milici et. al [13]	53	Male	No	Not mentioned	Not mentioned	Yes	Epigastric pain (Postprandial), Fever	5 cm	Not mentioned	Conservative	
Oka et. al [2]	56	Male	Yes	Alcohol	Chronic	Yes	Epigastric pain, Fever, Nausea, Vomiting	Not mentioned	24250 U/L	Conservative	
Radke et. al [3]	41	Male	Yes	Alcohol	Chronic	No	Epigastric pain (Radiating to back), Inability to gain weight	Not mentioned	7000 U/L	Laparotomy	
Radke et. al [3]	43	Male	Yes	Alcohol	Chronic	No	Epigastric pain, Fever, Nausea, Vomiting, Weight loss	Not mentioned	Not mentioned	Laparotomy	
Rana et. al [1]	54	Male	Yes	Alcohol	Acute	No	Abdominal pain	6 cm	Not mentioned	Conservative	
Rana et. al [1]	24	Male	Yes	Alcohol	Chronic	No	Abdominal pain	2 cm	Not mentioned	Surgery	
Rana et. al [1]	36	Male	Yes	Alcohol	Acute	No	Abdominal pain	4 cm	Not mentioned	Conservative	
Salazar et. al [14]	38	Male	Yes	Alcohol	Not mentioned	Yes	Abdominal pain	Not mentioned	Not mentioned	Surgery	
Søreide et. al [15]	56	Male	Yes	Alcohol	Yes, but the type not mentioned	Yes	Unspecific abdominal complaints	4.2 cm	Not mentioned	Conservative	
Søreide et. al [15]	69	Male	Yes	Alcohol	Chronic	No	Abdominal pain, Gastrointestinal bleeding	Not mentioned	Not mentioned	Endoscopic pancreatic stenting	
Søreide et. al [15]	73	Male	Yes	Alcohol	Yes, but the type not mentioned	No	Abdominal pain	Not mentioned	Not mentioned	Conservative	
Suraweera et. al [16]	41	Male	Yes	Alcohol	Chronic	Yes	Emesis (Nonbloody, Nonbilious), Epigastric pain, Nausea	1.2 cm	Not mentioned	Conservative	
Suraweera et. al [16]	63	Male	Yes	Alcohol	Chronic	Yes	Abdominal pain, Emesis (Nonbloody, Nonbilious), Nausea	Not mentioned	61500 U/L	EUS guided drainage	
Vitello et. al [17]	20	Male	Yes	Alcohol	Acute	Yes	Nausea, Vomiting	Not mentioned	240000 U / L	Surgery	
Wagholikar et. al [5]	37	Male	Yes	Alcohol	Acute	Yes	Vomiting (Non bilus, Postprandial)	Not mentioned	9742 U/L	US-guided percutaneous aspiration	
Zahlan et. al [18]	68	Male	Yes	Alcohol	Not mentioned	Not mentioned	Epigastric pain, Weight loss, Nausea, Vomiting	Not mentioned	Not mentioned	Surgery	
Our study	57	Male	No	Probably due to recurrent Biliary Obstruction	Chronic	Yes	Epigastric pain, Nausea, Vomiting (Post prandial, Nonbloody, Nonbilious)	6.5 cm	Not mentioned	Conservative	

Of the 25 patients, there were 23 males (92%) and 2 females (8%). The mean ± standard age of all patients was 47.68 ± 14.82, with a range of 20-73 years (Fig. 5). About 21 of the 25 patients (84%) had a history of abusive or chronic alcohol consumption. Three patients either did not mention pancreatitis, or we were unable to provide the necessary data. The remaining 22 patients confirmed positive for pancreatitis (88%): 10 had chronic pancreatitis, 7 had acute pancreatitis, 1 had Type 1 autoimmune pancreatitis (AIP), and 3 had no pancreatitis type mentioned. In 12 patients, the presence of a previous or current pancreatic pseudocyst was mentioned.Fig. 5 Characteristics of gastric pseudocysts reported in the literature including our case showing the median, mean, 25th percentile, 75th percentile, minimum, and maximum values.

Fig 5:

Common signs and symptoms were abdominal, especially epigastric pain (in 20 patients), vomiting or emesis (in 11 patients), nausea (in 9 patients), weight loss or inability to gain weight (in 4 patients), and fever (in 3 patients). Other symptoms were heartburn and gastrointestinal bleeding.

There were 14 patients with recorded intramural gastric pseudocyst sizes with a mean ± standard deviation of 4.02 ± 1.75 cm, ranging from 1.2 to 7.0 cm (Fig. 5). Measuring the amylase content of the gastric pseudocyst was done in 11 patients, with a mean ± standard deviation of 60,913.36 ± 72,862.76 U/L, ranging from 6320 U/L to 240,000 U/L (Fig. 5).

Laboratory data from the reported cases showed notable rises in total white blood cell count, serum amylase, serum lipase, and high C-reactive protein (CRP) levels.

Common treatment methods included conservative treatment (in 9 patients), different types of surgery (in 7 patients), and various nonsurgical methods of drainage using endoscopy, ultrasonography, fluoroscopy, and endoscopic ultrasound (in 9 patients).

One patient experienced a perforation into the stomach lumen and the formation of a hematoma. One patient passed away 6 months later in follow-up due to cardiac arrest (he had a comorbid medical history). The rest of the patients, for whom complications and outcomes were reported, had favorable and uneventful results.

Pathophysiology

As previously mentioned, H. M. Radke and J. W. Bell came up with the term “intramural gastric pseudocyst” in 1966 [3]; Since then, similar definitions and pathophysiology for this condition have been proposed, but they all point to the pancreatic tissue and pancreatic pseudocyst [19].

Pancreatic pseudocysts are accumulations of pancreatic secretions enclosed by a fibrous layer, usually appearing following an episode of acute or chronic pancreatitis [[20], [21], [22]].

Pancreatitis can cause the pancreatic ducts to rupture, resulting in enzyme leakage [23]. These enzymes, in addition to necrotic tissue and inflammatory cells, accumulate in the pancreas or surrounding tissue. Over time, a fibrous tissue wall develops around this collection, resulting in the formation of a pseudocyst that lacks an epithelial lining. The process entails enzymes digesting inflamed tissue and forming a fibrous capsule [[24], [25], [26]]. The absence of an epithelial layer categorizes these cystic pancreatic lesions as nonepithelial cystic pancreatic lesions [20].

Pancreatic pseudocysts can result from a variety of causes, including alcohol consumption, biliary tract disorders, traumatic injuries, and surgical procedures. Among these, alcohol is the primary and most influential factor [24,27].

Pancreatic-related pseudocysts are typically found in the peripancreatic region, but they have also been sporadically observed in unusual locations such as the stomach, duodenum, spleen, liver, mediastinum, pelvis, and kidney [1,19].

The exact pathophysiology of gastric intramural pseudocysts remains unclear, but based on reported cases and suggestions from current studies, there are some possibilities. After a pancreatic pseudocyst forms, it usually resolves without requiring an invasive procedure. However, complications such as rupture and pancreatic fistulas can occur [26,28,29].

In cases of leakage, rupture, or fistula formation with nearby organs, viscera, cavities, or vessels, especially the stomach due to its anatomical proximity to the pancreas, the contents of a pancreatic pseudocyst, which include amylase, lipase, and other proteolytic enzymes, can cause erosion, inflammation, and extension into the gastric wall layers [26,[30], [31], [32], [33], [34], [35], [36]]. This can lead to perforation of the gastric walls, particularly in the presence of gastric ulcers, allowing the pseudocyst contents to drain spontaneously into the stomach cavity, resulting in hematoma, gastrointestinal bleeding, ischemia, or gastritis [[37], [38], [39], [40]].

Alternatively, the pseudocyst may not cause perforation and instead remain within the gastric wall layers. A fibrous tissue wall can form around this collection over time, which is similar to how pancreatic pseudocysts form. This speculative process can lead to the formation of an intramural gastric pseudocyst.

Another detected pathological way of forming an intramural gastric pseudocyst is through an ectopic pancreas. Ectopic, or heterotopic pancreas, is a congenital disorder identified by the presence of pancreatic tissue that is anatomically distinct from the main pancreas and has its ductal system. This condition is mostly seen in the upper gastrointestinal tract, including the stomach, duodenum, and jejunum [41,42]. Ectopic pancreatic tissue is prone to the same complications as the main pancreas, such as pseudocyst formation. Pseudocysts may develop in ectopic pancreatic tissue as a result of pancreatitis or duct obstruction. In cases of ectopic lesions and pancreatitis, pseudocyst formation is a frequent occurrence [[41], [42], [43], [44], [45]].

Gastric intramural pseudocysts related to ectopic pancreas are not the main focus of this study due to their different etiology and underlying causes. However, we mention them in various sections because they share common features with intramural gastric pseudocysts associated with the main pancreas.

Diagnosis

Imaging modalities are instrumental in diagnosing intramural gastric pseudocysts. This condition can be diagnosed using ultrasonography (US), computed tomography (CT), magnetic resonance cholangiopancreatography (MRCP), and magnetic resonance imaging (MRI) [1,4,13,15,17].

Previous studies noted the use of the upper gastrointestinal series (UGI), which involves X-rays or fluoroscopy utilizing barium contrast [1,13,40].

To diagnose and understand the underlying cause of the disease more effectively, it is necessary to examine the pancreas using imaging techniques to identify the presence of pancreatitis (either chronic or acute), pancreatic pseudocysts, or any other complications in nearby organs. Contrast-enhanced computed tomography (CECT) is a valuable tool for confirming the presence of cystic lesions and identifying the characteristics of acute or chronic pancreatitis [1,4,5,12].

Upper gastrointestinal endoscopy and endoscopic ultrasound (EUS) are 2 other methods being used for evaluating intramural pseudocysts. EUS is considered the most reliable and effective modality for diagnosing and evaluating intramural gastric pseudocysts [1,36,46,47]. It is highly proficient at identifying the cyst contents and evaluating the different layers of the gastric wall. It is a very useful diagnostic tool for evaluating gastric submucosal tumors and cystic lesions. This method provides reliable information about the size, depth, internal features, and origin layer of these lesions [46,47].

Intramural gastric pseudocysts contain amylase-rich pancreatic fluid. To diagnose and confirm the origin of the disease, as well as to perform differential diagnosis, fluid aspiration from the cyst during EUS, endoscopy, or under ultrasonography guidance is utilized. The aspirated fluid is then examined for amylase levels; high amylase levels indicate a pancreatic source for the cystic lesion [1,5,8]. Additionally, carcinoembryonic antigen (CEA) levels are measured to distinguish between benign and malignant cystic lesions. Elevated CEA levels in the cyst fluid are more indicative of mucinous cystic neoplasms [[48], [49], [50]].

As a cystic structure, gastric intramural pseudocysts are similar to pancreatic pseudocysts in imaging studies. They appear as well-defined lesions arising from the gastric walls. Depending on the content of the cyst, which may include debris or necrotic tissue, the texture could be homogeneous or inhomogeneous on CT scans or may show internal echoes on ultrasound. The definite diagnosis of this condition is made through EUS and cyst fluid analysis, revealing high amylase content along with a correlation with the patient's medical history [16,51,52].

The differential diagnosis of intramural gastric pseudocysts involves differentiating them from other cystic lesions and masses in the stomach and adjacent structures. The most important differentials include pancreatic pseudocysts, mucinous cystic neoplasms, gastric submucosal tumors, duplication cysts, abscesses, gastrointestinal stromal tumors (GISTs), and leiomyomas [48,49,[53], [54], [55], [56], [57], [58], [59], [60]].

Management and treatments

The management of intramural gastric pseudocysts could be divided into 3 main treatment strategies: conservative management, surgical interventions, and nonsurgical interventions [[1], [2], [3], [4], [5],12,13]. Conservative management entails administering analgesics to relieve pain, prescribing intravenous fluids to maintain the patient's hydration and electrolyte balance, and using antibiotics to treat or prevent infection. Nonsurgical interventions are usually less invasive procedures, and they often have lower risks and fewer possible complications. Suggested nonsurgical interventions are drainage of the cyst under the guidance of fluoroscopy, ultrasonography, endoscopic aspiration, and EUS-guided aspiration [5,6,8,10,22].

Physicians usually choose the treatment methods based on the underlying cause, complications, patients’ clinical status, vital signs, and their individual preferences.

In cases of severe or significantly symptomatic patients, or when a definite diagnosis is unclear or there are other underlying causes in the stomach, EUS-guided diagnosis and drainage could be the best treatment method [6,8,10]. However, in cases of more severe and potentially fatal conditions with other pathologies needing surgery, surgical interventions such as laparotomy (like our case) and gastrotomy may be required [3,53].

Procedure-related complications following drainage of pseudocysts or surgical interventions can occur, such as hemorrhage or bleeding, gastric perforation, or infection [[61], [62], [63]].

In reported cases of intramural gastric pseudocysts, most patients had favorable outcomes without any significant complications, regardless of the treatment method. However, more research is required to establish the best guidelines for treating this condition.

Additionally, in cases with a current episode of pancreatitis or complicated pancreatic pseudocysts, such as ruptures, peritonitis, gastric perforations, hematoma, or gastrointestinal bleeding, appropriate management of these complications is essential [6,7,9,10,14,16]. Furthermore, in the presence of ectopic pancreas, treatment strategies may differ, necessitating distinct strategies [42,44,45].

Discussion

Only case reports and case studies have reported intramural gastric pseudocysts, making them extremely rare. Due to a lack of literature, it was important to discuss the pathophysiology, clinical presentation, patient profile, diagnostic methods, and treatment options of intramural gastric pseudocysts to effectively manage the disease and help with future research on it. To achieve this goal, we designed this case report and followed it with a literature review that provided an overview of reported cases.

Our reported case, a 57-year-old man with a history of chronic pancreatitis but no history of alcohol consumption, fits the common demographic identified in the literature. This deviation highlights the need for further research on intramural gastric pseudocysts, especially in populations with lower alcohol consumption.

Our case demonstrated an incidence of recurrence in the condition which is rarely seen in the available literature. This recurrence could be attributed to the patient's recurrent CBD stone formation or chronic pancreatitis. The patient's gastric pseudocysts were diagnosed in all imaging studies following the first surgery suggesting a possible link between the procedures performed on pancreatic pseudocysts and the recurrence. This observation warrants further evaluation and more research to understand the underlying mechanisms and potential contributing factors.

Our literature review and analysis of reported cases indicate that intramural gastric pseudocysts predominantly occur in middle-aged males (37–57 years) with a history of chronic or abusive alcohol consumption and pancreatitis.

Based on the suggested pathophysiology in the literature, there is a link between pancreatitis and pseudocyst formation in the pancreas with intramural gastric pseudocysts. Our analysis shows that nearly half of the patients had a history of diagnosed pancreatic pseudocysts.

The most common symptoms were abdominal pain, usually epigastric, nausea, vomiting, weight loss, and fever. These symptoms are not fully specific and can be seen in many gastrointestinal disorders.

Endoscopic ultrasonography (EUS) is the most effective method for diagnosing intramural gastric pseudocysts [36]. Endoscopic ultrasound (EUS) can be used to extract fluid from the cyst to examine the levels of amylase and carcinoembryonic antigen (CEA), which may help in differential diagnosis [48,49]. In addition, EUS offers comprehensive data on the lesion, making it an excellent tool for differentiating intramural gastric pseudocysts from other ailments. Additionally, it can serve therapeutic purposes like cyst drainage [46,47].

In our reported case, EUS and cyst fluid analysis were not performed because the cause of the patient's symptoms and referral to the hospital was believed to be recurrent biliary obstruction caused by CBD stones with the underlying cause of recurrent chronic pancreatitis.

As stated in Fig. 1, the patient's findings suggested acute necrotizing pancreatitis and pseudocyst formation simultaneously. Pancreatic pseudocysts usually mature and can be detected weeks after a necrotizing pancreatitis episode [21]. The patient's history of chronic pancreatitis could justify this coexistence. This episode could represent an acute-on-chronic pancreatitis episode.

There are several treatment options for intramural gastric pseudocysts, including surgery, nonsurgical interventions, and conservative management. Following conservative strategies (like our case) requires a comprehensive assessment of the patient's condition [1,5,13].

Different imaging modalities and radiologic features in computed tomography (CT), ultrasonography (US), and other modalities have been instrumental in diagnosing conditions like pancreatic and gastric pseudocysts for many years.

Our report demonstrated some of the disease's radiologic features and highlighted the diagnostic challenges associated with its rarity.

There is still a need for more research and study to better understand the pathophysiology of the disease and to provide more accurate management guidelines in the future.

Conclusion

Intramural gastric pseudocyst is a very rare condition and typically can be seen in middle-aged males (37-57 years old) with a history of chronic or abusive alcohol use and pancreatitis.

More research is needed in the future to determine the pathophysiology and most effective treatment strategies for intramural gastric pseudocysts.

Patient consent

We have obtained written informed consent from the patient to publish his case, including the use of medical history, clinical data, laboratory data, and images.

Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
==== Refs
References

1 Rana S Bhasin D Rao C Gupta R. Intramural pseudocysts of the upper gastrointestinal tract Endosc Ultrasound [Internet] 2 4 2013 194 Available from https://journals.lww.com/eusjournal/fulltext/2013/02040/intramural_pseudocysts_of_the_upper.4.aspx 24949395
2 Oka A Amano Y Uchida Y Kagawa K Tada Y Kusunoki R Gastric intramural pseudocyst Pancreas [Internet] 42 1 2013 182 184 Available from https://pubmed.ncbi.nlm.nih.gov/23254919/ 23254919
3 Radke HM Bell JW. Gastric Intramural Pseudocyst in Chronic pancreatitis Am J Surg [Internet] 111 4 1966 584 586 Available from https://pubmed.ncbi.nlm.nih.gov/5910669/ 5910669
4 Koop I MÜnnikes H Fehmann C Schwerk WB HÜgens-Penzel HM Rothmund M Intramural pancreatic pseudocyst in the gastric wall J Clin Gastroenterol [Internet] 12 4 1990 466 469 Available from https://pubmed.ncbi.nlm.nih.gov/2204656/ 2204656
5 Wagholikar GD Ibrarullah M Venkataramanapa M. Gastric intramural pseudocyst: a complication of percutaneous drainage of an acute pancreatic pseudocyst Am J Gastroenterol [Internet] 98 1 2003 229 231 Available from https://journals.lww.com/ajg/citation/2003/01000/gastric_intramural_pseudocyst__a_complication_of.59.aspx 12526979
6 Ahuja N Mok Johal AS Diehl DL Intragastric Pseudocyst: 2017 Presidential Poster Award: 1376 Official J Am Coll Gastroenterol [Internet] 112 2017 S745 Available from https://journals.lww.com/ajg/fulltext/2017/10001/intragastric_pseudocyst__2017_presidential_poster.1377.aspx
7 Atiq I Khan A Turki M Frandah W Sherif A. S3380 gastric intramural pseudocyst causing gastric outlet obstruction: awareness and management with a rare case presentation Am J Gastroenterol 118 10S 2023 S2237
8 Chiu H Liu Y Li JH. Gastric intramural pseudocyst presenting as a gastric submucosal lesion Clin Gastroenterol Hepatol [Internet] 5 6 2007 e20 e21 Available from https://pubmed.ncbi.nlm.nih.gov/17544987/ 17544987
9 Dong Y Li J. Spontaneous drainage of a pancreatic pseudocyst into the stomach Revista Española De Enfermedades digestivas/Revista Española De Enfermedades Digestivas 115 2022 95
10 Hatamori H Wada M Taniguchi Y Inokuma T. Pancreatic pseudocyst localized in the gastric wall after EUS-guided FNA of type 1 autoimmune pancreatitis Gastrointest Endosc 86 5 2017 919 921 28583768
11 Kumar A Balekuduru A Reddivari K Locheruvapalli L Kiran R Subbaraj SB Abstracts—Indian Society of Gastroenterology Indian J Gastroenterol 36 S1 2017 1 105
12 Luigiano C Cennamo V Ferrara F Fabbri C. Endoscopic ultrasound-fine needle aspiration diagnosis and treatment of a gastric intramural pseudocyst Digest Liver Disease/Digest Liver Dis [Internet] 44 8 2012 e18 Available from https://pubmed.ncbi.nlm.nih.gov/22445293/
13 Milici LP Markowitz SK. Gastric intramural pseudocyst: computed tomographic diagnosis Gastrointest Radiol [Internet] 14 1 1989 113 114 Available from https://pubmed.ncbi.nlm.nih.gov/2707537/ 2707537
14 Je S Novick M I M Pancreatic pseudocyst: an unusual presentation as a gastric intramural mass PubMed 74 8 1981 559 562
15 Søreide JA Al-Saiddi MSS Karlsen LN. Intramural gastric pseudocyst Medicine [Internet]. 96 50 2017 e9157 Available from https://pubmed.ncbi.nlm.nih.gov/29390322/ 29390322
16 Suraweera D Weiss GA Mohammad S Singhvi G. Gastric intramural pseudocyst: a rare complication of chronic pancreatitis: 1142 Off J Am Coll Gastroenter[Internet] 110 2015 S497 S498 Available from https://journals.lww.com/ajg/fulltext/2015/10001/gastric_intramural_pseudocyst__a_rare_complication.1142.aspx
17 Vitello JM. Gastric intramural pseudocyst with associated gastric outlet obstruction: recognition and management South Med J [Internet]. 89 5 1996 534 537 Available from https://pubmed.ncbi.nlm.nih.gov/8638187/ 8638187
18 Zahlan B Pm B Merran S Bourdon-Conochie F Jabbari M Ag T Gastric intramural pseudocyst of the pancreas PubMed 39 4 1988 282 283
19 Bhasin DK Rana SS Nanda M Chandail VS Masoodi I Kang M Endoscopic management of pancreatic pseudocysts at atypical locations Surg Endosc/Surg Endosc Other Intervent Techn [Internet] 24 5 2009 1085 1091 Available from https://link.springer.com/article/10.1007/s00464-009-0732-8
20 Banks PA Bollen TL Dervenis C Gooszen HG Johnson CD Sarr MG Classification of acute pancreatitis—2012: revision of the Atlanta Classification and Definitions by International Consensus Gut [Internet]. 62 1 2012 102 111 Available from https://pubmed.ncbi.nlm.nih.gov/23100216/ 23100216
21 Koo JG Liau MYQ Kryvoruchko IA Habeeb TA Chia C Shelat VG. Pancreatic pseudocyst: the past, the present, and the future World J Gastrointest Surg 16 7 2024 1986 2002 39087130
22 Keshavarz P Azrumelashvili T Yazdanpanah F Nejati SF Ebrahimian Sadabad F Tarjan A Percutaneous catheter drainage of pancreatic associated pathologies: a systematic review and meta-analysis Eur J Radiol 144 2021 109978
23 Mizandari M Azrumelashvili T Keshavarz P Habib N. Image-guided percutaneous pancreatic duct drainage: a 10-year observational study J Vasc Interv Radiol 32 7 2021 1075 1080.e2 33857612
24 Pitchumoni CS Agarwal N. Pancreatic pseudocysts Gastroenterol Clin North Am [Internet] 28 3 1999 615 639 Available from https://pubmed.ncbi.nlm.nih.gov/10503140/ 10503140
25 Habashi S Draganov PV Pancreatic pseudocyst World J Gastroenterol [Internet] 15 1 2009 38 Available from https://pubmed.ncbi.nlm.nih.gov/19115466/ 19115466
26 Damaskos C Prevezanos D Garmpis N Garmpi A Kouraklis G Dimitroulis D. Pancreatic Pseudocyst 2023 IntechOpen London, UK
27 Walt AJ Bouwman DL Weaver DW Sachs RJ. The impact of technology on the management of pancreatic pseudocyst Arch Surg [Internet] 125 6 1990 759 Available from https://pubmed.ncbi.nlm.nih.gov/2189377/ 2189377
28 El Kurdi B S Babar Haddad I Aasen T El Iskandarani M Goenka P 3037 spontaneous cystgastrostomy from pancreatic pseudocyst erosion into gastric wall resulting in gastrointestinal hemorrhage Am J Gastroenterol 114 1 2019 S1639
29 Mariappan K Indiran V. Pancreatic pseudocyst with simultaneous gastric and colonic fistulization Vis J Emerg Med 25 2021 101180
30 Patidar Y Sureka B Singh VP Bansal K Maiwall R. Spontaneous rupture of intrahepatic pseudocyst into the inferior vena cava Gastroenterol Rep (Oxf) [Internet] 6 2016 225 227 Available from https://pubmed.ncbi.nlm.nih.gov/27103737/ 27103737
31 Rocha R Marinho R Gomes A Sousa M Pignatelli N Carneiro C Spontaneous rupture of pancreatic pseudocyst: report of two cases Case Rep Surg [Internet] 2016 2016 1 3 Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818817/
32 Urakami A Tsunoda T Hayashi J Oka Y Mizuno M. Spontaneous fistulization of a pancreatic pseudocyst into the colon and duodenum Gastrointest Endosc [Internet] 55 7 2002 949 951 Available from https://www.giejournal.org/article/S0016-5107(02)64424-4/abstract 12024164
33 Madani MA Ouannes Y Chaker K Marrak M Nouira Y. Pancreatic pseudocyst mimicking a left kidney abscess: a case report J Med Case Rep [Internet] 17 1 2023 228 Available from https://pubmed.ncbi.nlm.nih.gov/37254204/ 37254204
34 Navarro F Leiva L Norero E. Acute Abdomen Due to Pancreatic pseudocyst with splenic extension and rupture J Surg Case Rep [Internet] 2021 4 2021 1 3 Available from https://academic.oup.com/jscr/article/2021/4/rjab071/6232348
35 Son TQ Hoc TH Huong TT Dinh NQ Van Tuyen P A Ruptured pancreatic pseudocyst causes acute peritonitis with clinical characteristics of a gastrointestinal tract perforation J Surg Case Rep [Internet] 2022 5 2022 1 4 Available from https://pubmed.ncbi.nlm.nih.gov/35665383/
36 Oh JY Nam KJ Choi JC Cho JH Yoon SK Choi SS Benign submucosal lesions of the stomach and duodenum: imaging characteristics with endoscopic and pathologic correlation Eur J Radiol [Internet] 67 1 2008 112 124 Available from https://pubmed.ncbi.nlm.nih.gov/17720347/ 17720347
37 Hsu CY Lee KC Chan CC Lee FY Lin HC. Gastric necrosis and perforation as a severe complication of pancreatic pseudocyst J Chin Med Assoc 72 11 2009 603 606 19948439
38 Jin Z Xiang YW Liao QS Yang XX Wu HC Tuo BG Massive gastric bleeding - perforation of pancreatic pseudocyst into the stomach: a case report and review of literature World J Clin Cases 9 2 2021 389 395 33521106
39 Katz K Shafqet M. Osteopetrosis: a rare cause of portal hypertension Am J Gastroenterol 109 2014 S222 25289903
40 Ladlow OJ Loveluck M Naidoo P Bohmer R. Gastric ischaemia: an unseen complication of pancreatic pseudocyst ANZ J Surg [Internet]. 92 3 2021 616 618 Available from https://pubmed.ncbi.nlm.nih.gov/34387921/ 34387921
41 Rezvani M Menias C Sandrasegaran K Olpin JD Elsayes KM Shaaban AM. Heterotopic pancreas: histopathologic features, imaging findings, and complications Radiographics [Internet] 37 2 2017 484 499 Available from https://pubmed.ncbi.nlm.nih.gov/28287935/ 28287935
42 Lee SL Ku YM Lee HH Cho YS. Gastric ectopic pancreas complicated by formation of a pseudocyst Clin Res Hepatol Gastroenterol [Internet] 38 4 2014 389 391 Available from https://pubmed.ncbi.nlm.nih.gov/24726272/ 24726272
43 LeCompte MT Mason B Robbins KJ Yano M Chatterjee D Fields RC Clinical classification of symptomatic heterotopic pancreas of the stomach and duodenum: a case series and systematic literature review World J Gastroenterol [Internet] 28 14 2022 1455 1478 Available from https://pubmed.ncbi.nlm.nih.gov/35582670/ 35582670
44 Dickerson A Farrell A Bushra A Celinski S Konda VJA Kale H Gastric Ectopic Pancreas with Pseudocyst Formation Causing Gastric Outlet Obstruction ACG Case Rep J [Internet] 10 2 2023 e00988 Available from https://pubmed.ncbi.nlm.nih.gov/36788791/
45 Kim JH Lee J Na JE Park YE Park J Kim TO Gastric outlet obstruction caused by gastric ectopic pancreas with pseudocyst formation. the korean journal of helicobacter and upper gastrointestinal research Korean J Helicob Upper Gastrointest Res 24 1 2024 82 85
46 Hizawa K Matsumoto T Kouzuki T Suekane H Esaki M Fujishima M. Cystic Submucosal tumors in the gastrointestinal tract: endosonographic findings and endoscopic removal Endoscopy [Internet] 32 9 2000 712 714 Available from https://pubmed.ncbi.nlm.nih.gov/10989996/ 10989996
47 Rösch T Lorenz R Dancygier H Von Wichert A Classen M Endosonographic diagnosis of submucosal upper gastrointestinal tract tumors Scand J Gastroenterol [Internet] 27 1 1992 1 8 Available from https://pubmed.ncbi.nlm.nih.gov/1736335/ 1736335
48 Talar-Wojnarowska R Pazurek M Durko L Degowska M Rydzewska G Smigielski J Pancreatic cyst fluid analysis for differential diagnosis between benign and malignant lesions Oncol Lett [Internet] 5 2 2012 613 616 Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573134/ 23420052
49 Brugge WR Lewandrowski K Lee-Lewandrowski E Centeno BA Szydlo T Regan S Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study Gastroenterology [Internet] 126 5 2004 1330 1336 Available from https://pubmed.ncbi.nlm.nih.gov/15131794/ 15131794
50 Van D Porte RJ Cyst Fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis Gastrointest Endosc [Internet] 62 3 2005 383 389 Available from https://pubmed.ncbi.nlm.nih.gov/16111956/ 16111956
51 Yacoub JH Clark JA Paal EE Manning MA. Approach to cystic lesions in the abdomen and pelvis, with radiologic-pathologic correlation Radiographics 41 5 Sep 2021 1368 1386 34469214
52 Brugge WR. Diagnosis and management of cystic lesions of the pancreas J Gastrointest Oncol 6 4 Aug 2015 375 388 26261724
53 Rowling JT. Some observations on gastric cysts British Journal of Surgery [Internet] 46 199 1959 441 445 Available from https://pubmed.ncbi.nlm.nih.gov/13651616/ 13651616
54 Kuraoka K Nakayama H Kagawa T Ichikawa T Yasui W. Adenocarcinoma arising from a gastric duplication cyst with invasion to the stomach: a case report with literature review J Clin Pathol [Internet] 57 4 2004 428 431 Available from https://pubmed.ncbi.nlm.nih.gov/15047751/ 15047751
55 Davies S Morris-Stiff G Lewis MH. Gastric duplication cyst mimicking a pancreatic pseudocyst in a patient with chronic pancreatitis Int J Surg [Internet] 6 6 2008 e70 e71 Available from https://pubmed.ncbi.nlm.nih.gov/17499033/ 17499033
56 Tseng KC Hsieh YH Tseng CA Lin CW Chen CY. Spontaneous regression of pancreatic pseudocyst mimicking a submucosal tumor of the stomach with upper gastrointestinal bleeding: report of a case J Intern Med Taiwan [Internet] 17 3 2006 128 132 Available from https://www.scopus.com/inward/record.uri?eid=2s2.033746601780&partnerID=40&md5=08069d865520aedcf3035f9af0109754
57 Will U Masri R Bosseckert H Knopke A Schönlebe J Justus J. Gastric wall abscess, a rare endosonographic differential diagnosis of intramural tumors: successful endoscopic treatment Endoscopy [Internet] 30 04 1998 432 435 Available from https://pubmed.ncbi.nlm.nih.gov/9689523/ 9689523
58 Hwang JH Rulyak SD Kimmey MB. American Gastroenterological Association Institute Technical review on the management of gastric subepithelial masses Gastroenterology [Internet] 130 7 2006 2217 2228 Available from https://pubmed.ncbi.nlm.nih.gov/16762644/ 16762644
59 Kim GH Kim DU Song GA Heo J Kim KY Choi SH. Endosonographic features of gastric gastrointestinal stromal tumors (GISTs): is it possible to differentiate gists from leiomyomas by EUS? Gastrointest Endosc [Internet] 69 5 2009 AB237 Available from https://www.giejournal.org/article/S0016-5107(09)01075-X/abstract#:~:text=Conclusions%3A%20The%20EUS%20features%20such,to%20differentiate%20GISTs%20from%20leiomyomas
60 Mardi K Kaushal V Gupta S. Foregut duplication cysts of stomach masquerading as leiomyoma Indian J Pathol Microbiol [Internet] 53 4 2010 829 Available from https://pubmed.ncbi.nlm.nih.gov/21045433/ 21045433
61 Rana S Complications of endoscopic ultrasound-guided transmural drainage of pancreatic fluid collections and their management Ann Gastroenterol 32 5 2019 441 450 31474789
62 Mizuide M Ryozawa S Fujita A Ogawa T Katsuda H Suzuki M Complications of endoscopic ultrasound-guided fine needle aspiration: a narrative review Diagnostics 10 11 2020 964 33213103
63 Nealon WH Walser E. Surgical management of complications associated with percutaneous and/or endoscopic management of pseudocyst of the pancreas Ann Surg 241 6 2005 948 960 15912044
